These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17932246)

  • 21. Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics: current status.
    Kowalski TJ; Sasikumar T
    BioDrugs; 2007; 21(5):311-21. PubMed ID: 17896837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties.
    Dyck B; Markison S; Zhao L; Tamiya J; Grey J; Rowbottom MW; Zhang M; Vickers T; Sorensen K; Norton C; Wen J; Heise CE; Saunders J; Conlon P; Madan A; Schwarz D; Goodfellow VS
    J Med Chem; 2006 Jun; 49(13):3753-6. PubMed ID: 16789729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.
    Jiang J; Hoang M; Young JR; Chaung D; Eid R; Turner C; Lin P; Tong X; Wang J; Tan C; Feighner S; Palyha O; Hreniuk DL; Pan J; Sailer AW; MacNeil DJ; Howard A; Shearman L; Stribling S; Camacho R; Strack A; Van der Ploeg LH; Goulet MT; DeVita RJ
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5270-4. PubMed ID: 16919456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice.
    Ito M; Ishihara A; Gomori A; Egashira S; Matsushita H; Mashiko S; Ito J; Ito M; Nakase K; Haga Y; Iwaasa H; Suzuki T; Ohtake N; Moriya M; Sato N; MacNeil DJ; Takenaga N; Tokita S; Kanatani A
    Eur J Pharmacol; 2009 Dec; 624(1-3):77-83. PubMed ID: 19836369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a selective radioligand for melanin-concentrating hormone 1-receptor (MCH1R).
    Ito M; Sakamoto T; Suzuki T; Egashira S; Moriya M; Ishihara A; Iwaasa H; Matsushita H; Nakase K; Wallace MA; Dean D; Sato N; Tokita S; Kanatani A
    Bioorg Med Chem Lett; 2009 May; 19(10):2835-9. PubMed ID: 19361985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice.
    Oh KS; Ryu SY; Lee S; Seo HW; Oh BK; Kim YS; Lee BH
    J Ethnopharmacol; 2009 Mar; 122(2):216-20. PubMed ID: 19330910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.
    Luthin DR
    Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732.
    Kim YM; An JJ; Jin YJ; Rhee Y; Cha BS; Lee HC; Lim SK
    J Mol Endocrinol; 2007 Apr; 38(4):455-65. PubMed ID: 17446235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
    Hadcock JR; Griffith DA; Iredale PA; Carpino PA; Dow RL; Black SC; O'Connor R; Gautreau D; Lizano JS; Ward K; Hargrove DM; Kelly-Sullivan D; Scott DO
    Biochem Biophys Res Commun; 2010 Apr; 394(2):366-71. PubMed ID: 20211605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice.
    Gomori A; Ishihara A; Ito M; Matsushita H; Ito M; Mashiko S; Iwaasa H; Matsuda M; Bednarek MA; Qian S; Macneil DJ; Kanatani A
    Br J Pharmacol; 2007 Jul; 151(6):900-8. PubMed ID: 17519948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity.
    Palani A; Shapiro S; McBriar MD; Clader JW; Greenlee WJ; Spar B; Kowalski TJ; Farley C; Cook J; van Heek M; Weig B; O'neill K; Graziano M; Hawes B
    J Med Chem; 2005 Jul; 48(15):4746-9. PubMed ID: 16033253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.
    Chen W; Tang H; Liu H; Long L; Gong Z; Zheng J; Chi M; Xie Y; Zheng Z; Li S; Wang L
    Eur J Pharmacol; 2010 Jul; 637(1-3):178-85. PubMed ID: 20380831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity.
    Dudek M; Marcinkowska M; Bucki A; Olczyk A; Kołaczkowski M
    Metab Brain Dis; 2015 Dec; 30(6):1487-94. PubMed ID: 26419385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of leptin on melanin-concentrating hormone expression in the brain of lean and obese Lep(ob)/Lep(ob) mice.
    Huang Q; Viale A; Picard F; Nahon J; Richard D
    Neuroendocrinology; 1999 Mar; 69(3):145-53. PubMed ID: 10087446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and evaluation of MCH receptor 1 antagonists--Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414.
    Müller SG; Heckel A; Kley JT; Lehmann T; Lustenberger P; Oost T; Roth GJ; Rudolf K; Arndt K; Lenter M; Lotz RR; Maier GM; Markert M; Schindler M; Stenkamp D
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3264-9. PubMed ID: 26112443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity.
    Rivera G; Bocanegra-García V; Galiano S; Cirauqui N; Ceras J; Pérez S; Aldana I; Monge A
    Curr Med Chem; 2008; 15(10):1025-43. PubMed ID: 18393860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Cheon HG
    Handb Exp Pharmacol; 2012; (209):383-403. PubMed ID: 22249825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.
    Kym PR; Iyengar R; Souers AJ; Lynch JK; Judd AS; Gao J; Freeman J; Mulhern M; Zhao G; Vasudevan A; Wodka D; Blackburn C; Brown J; Che JL; Cullis C; Lai SJ; LaMarche MJ; Marsilje T; Roses J; Sells T; Geddes B; Govek E; Patane M; Fry D; Dayton BD; Brodjian S; Falls D; Brune M; Bush E; Shapiro R; Knourek-Segel V; Fey T; McDowell C; Reinhart GA; Preusser LC; Marsh K; Hernandez L; Sham HL; Collins CA
    J Med Chem; 2005 Sep; 48(19):5888-91. PubMed ID: 16161992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity.
    Air EL; Strowski MZ; Benoit SC; Conarello SL; Salituro GM; Guan XM; Liu K; Woods SC; Zhang BB
    Nat Med; 2002 Feb; 8(2):179-83. PubMed ID: 11821903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.